Constitutive activation of the renin-angiotensin system reduces visceral fat and improves glucose tolerance in mice

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 15, Issue 4, 2014, Pages 396-409

  Favre, Guillaume A ^a,b,c,d   Lebrun, Patricia ^a,b,c   Lopez, Pascal ^a,b,c   Butori, Catherine ^d   Hofman, Paul ^c,d   Esnault, Vincent L M ^a,b,c,d   Van Obberghen, Emmanuel ^a,b,c,d  

^a INSERM   (France)

^b UNIVERSITY OF NICE SOPHIA ANTIPOLIS   (France)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

Author keywords

metabolism; renal function; Renin angiotensin system

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CREATININE; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; PROTEIN; RAMIPRIL; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER 2; ANGIOTENSIN II; INSULIN;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; ENERGY BALANCE; ENERGY CONSUMPTION; ENZYME INHIBITION; EPIDIDYMIS FAT; FAT MASS; FEMALE; FOOD INTAKE; GLOMERULUS FILTRATION RATE; GLUCOSE HOMEOSTASIS; GLUCOSE INTAKE; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HISTOPATHOLOGY; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; INTRAABDOMINAL FAT; KIDNEY FUNCTION; KIDNEY TUBULE; LIPID DIET; LOCOMOTION; MALE; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; POLYDIPSIA; PROTEIN ELECTROPHORESIS; PROTEIN URINE LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECTUM TEMPERATURE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINE VOLUME; WEIGHT GAIN; WHITE ADIPOSE TISSUE; ANIMAL; AREA UNDER THE CURVE; BLOOD; C57BL MOUSE; DRINKING; DRUG EFFECTS; ENERGY METABOLISM; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; HYPERTENSION; KIDNEY FUNCTION TEST; KIDNEY PROXIMAL TUBULE; METABOLISM; MUSCLE; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; SECRETION (PROCESS); TRANSGENIC MOUSE; ULTRASTRUCTURE;

ANGIOTENSIN II; ANIMALS; AREA UNDER CURVE; CREATININE; DRINKING; ENERGY METABOLISM; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; HYPERTENSION; INSULIN; INTRA-ABDOMINAL FAT; KIDNEY FUNCTION TESTS; KIDNEY TUBULES, PROXIMAL; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLES; ORGAN SIZE; PHENOTYPE; RAMIPRIL; RENIN-ANGIOTENSIN SYSTEM;

EID: 84918580860     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320314537695     Document Type: Article

References (48)

1. Shum M, Pinard S, Guimond MO, et al. Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats. Am J Physiol Endocrinol Metab. 2013 ; 304: E197 - E210
2. Yvan-Charvet L, Even P, Bloch-Faure M, et al. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes. 2005 ; 54: 991-999
3. Cassis LA, Marshall DE, Fettinger MJ, et al. Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol. 1998 ; 274 (5). E867 - E876
4. Kouyama R, Suganami T, Nishida J, et al. Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology. 2005 ; 146: 3481-3489
5. Takahashi N, Li F, Hua K, et al. Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab. 2007 ; 6: 506-512
6. Gratze P, Boschmann M, Dechend R, et al. Energy metabolism in human renin-gene transgenic rats: Does renin contribute to obesity?. Hypertension. 2009 ; 53: 516-523
7. Gubler MC, Antignac C. Renin-angiotensin system in kidney development: Renal tubular dysgenesis. Kidney Int. 2010 ; 77: 400-406
8. Crowley SD, Gurley SB, Herrera MJ, et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA. 2006 ; 103: 17985-17990
9. Massiera F, Seydoux J, Geloen A, et al. Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology. 2001 ; 142: 5220-5225
10. Sugaya T, Nishimatsu S, Tanimoto K, et al. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem. 1995 ; 270: 18719-18722
11. Takahashi N, Lopez ML, Cowhig JE, et al. Ren1c homozygous null mice are hypotensive and polyuric, but heterozygotes are indistinguishable from wild-type. J Am Soc Nephrol. 2005 ; 16: 125-132
12. Tanimoto K, Sugiyama F, Goto Y, et al. Angiotensinogen-deficient mice with hypotension. J Biol Chem. 1994 ; 269: 31334-31337
13. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008 ; 73: 391-398
14. Pelletier CC, Koppe L, Croze ML, et al. White adipose tissue overproduces the lipid-mobilizing factor zinc alpha2-glycoprotein in chronic kidney disease. Kidney Int. 2013 ; 83: 878-886
15. Kai T, Shimada S, Sugimura K, et al. Tissue-localized angiotensin II enhances cardiac and renal disorders in Tsukuba hypertensive mice. J Hypertens. 1998 ; 16 (12). 2045-2049
16. Shimokama T, Haraoka S, Horiguchi H, et al. The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: Development of lesions and morphometric analysis. Virchows Arch. 1998 ; 432: 169-175
17. Lee MH, Song HK, Ko GJ, et al. Angiotensin receptor blockers improve insulin resistance in type 2 diabetic rats by modulating adipose tissue. Kidney Int. 2008 ; 74: 890-900
18. Sloniger JA, Saengsirisuwan V, Diehl CJ, et al. Selective angiotensin II receptor antagonism enhances whole-body insulin sensitivity and muscle glucose transport in hypertensive TG(mREN2)27 rats. Metabolism. 2005 ; 54: 1659-1668
19. Hitomi H, Kiyomoto H, Nishiyama A. Angiotensin II and oxidative stress. Curr Opin Cardiol. 2007 ; 22: 311-315
20. Engeli S, Bohnke J, Gorzelniak K, et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension. 2005 ; 45: 356-362
21. Goodfriend TL, Kelley DE, Goodpaster BH, et al. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res. 1999 ; 7: 355-362
22. Giacchetti G, Faloia E, Mariniello B, et al. Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens. 2002 ; 15: 381-388
23. Massiéra F, Bloch-Faure M, Ceiler D, et al. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J. 2001 ; 15: 2727-2729
24. Fletcher SJ, Kalupahana NS, Soltani-Bejnood M, et al. Transgenic mice overexpressing renin exhibit glucose intolerance and diet-genotype interactions. Front Endocrinol (Lausanne). 2013 ; 3: 166
25. Rodriguez R, Viscarra JA, Minas JN, et al. Angiotensin receptor blockade increases pancreatic insulin secretion and decreases glucose intolerance during glucose supplementation in a model of metabolic syndrome. Endocrinology. 2012 ; 153: 1684-1695
26. Santos SH, Braga JF, Mario EG, et al. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7). Arterioscler Thromb Vasc Biol. 2010 ; 30: 953-961
27. Andraws R, Brown DL. Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials). Am J Cardiol. 2007 ; 99: 1006-1012
28. Bosch J, Yusuf S, Gerstein HC, et al. Effect of ramipril on the incidence of diabetes. N Engl J Med. 2006 ; 355: 1551-1562
29. Merrill DC, Thompson MW, Carney CL, et al. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest. 1996 ; 97: 1047-1055
30. Grobe JL, Grobe CL, Beltz TG, et al. The brain renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab. 2010 ; 12: 431-442
31. Sigmund CD, Jones CA, Kane CM, et al. Regulated tissue- and cell-specific expression of the human renin gene in transgenic mice. Circ Res. 1992 ; 70: 1070-1079
32. Sigmund CD. Expression of the human renin gene in transgenic mice throughout ontogeny. Pediatr Nephrol. 1993 ; 7: 639-645
33. Yang G, Merrill DC, Thompson MW, et al. Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem. 1994 ; 269: 32497-32502
34. Davisson RL, Yang G, Beltz TG, et al. The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes. Circ Res. 1998 ; 83: 1047-1058
35. Krege JH, Hodgin JB, Hagaman JR, et al. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension. 1995 ; 25: 1111-1115
36. Heydrick SJ, Jullien D, Gautier N, et al. Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest. 1993 ; 91: 1358-1366
37. Deschenes G, Doucet A. Collecting duct (Na+/K+)-ATPase activity is correlated with urinary sodium excretion in rat nephrotic syndromes. J Am Soc Nephrol. 2000 ; 11: 604-615
38. Elalouf JM, Buhler JM, Tessiot C, et al. Predominant expression of beta 1-adrenergic receptor in the thick ascending limb of rat kidney. Absolute mRNA quantitation by reverse transcription and polymerase chain reaction. J Clin Invest. 1993 ; 91: 264-272
39. Piraud M, Vianey-Saban C, Bourdin C, et al. A new reversed-phase liquid chromatographic/tandem mass spectrometric method for analysis of underivatised amino acids: Evaluation for the diagnosis and the management of inherited disorders of amino acid metabolism. Rapid Commun Mass Spectrom. 2005 ; 19: 3287-3297
40. Sakai K, Agassandian K, Morimoto S, et al. Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest. 2007 ; 117: 1088-1095
41. Porter JP, Anderson JM, Robison RJ, et al. Effect of central angiotensin II on body weight gain in young rats. Brain Res. 2003 ; 959: 20-28
42. Porter JP, Potratz KR. Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am J Physiol Regul Integr Comp Physiol. 2004 ; 287: R422 - R428
43. Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int. 2011 ; 80: 17-28
44. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005 ; 67: 2089-2100
45. Takimoto E, Ishida J, Sugiyama F, et al. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 1996 ; 274: 995-998
46. Thornton SN, Omouessi ST, Falconetti C. Mineralocorticoid modulation of central angiotensin-induced neuronal activity, water intake and sodium appetite. Braz J Med Biol Res. 2007 ; 40: 699-705
47. Gordon SE, Davis BS, Carlson CJ, et al. ANG II is required for optimal overload-induced skeletal muscle hypertrophy. Am J Physiol Endocrinol Metab. 2001 ; 280: E150 - E159
48. Putnam K, Shoemaker R, Yiannikouris F, et al. The renin-angiotensin system: A target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. Am J Physiol Heart Circ Physiol. 2012 ; 302: H1219 - H1230